"What" Series

What is the storage method for radioactive drugs?

23 April 2024
2 min read

The storage method for radioactive drugs needs to follow specific safety and protection standards to ensure the safety and effectiveness of radioactive substances. According to the provided resource information, here are some key points regarding the storage method for radioactive drugs:

· Storage facilities: Radioactive drugs should be stored in dedicated areas that meet radiation protection requirements. These areas should have proper shielding to reduce radiation leakage, and should have warning signs to remind people of the presence of radioactive substances.

· Storage containers: Radioactive drugs should be stored in containers with sufficient shielding, and these containers should have ionizing radiation signs on the surface to prevent radiation leakage and accidental contact.

· Classified storage: Radioactive waste should be collected and treated separately according to the type of radioactive nuclides, half-life, activity level, and physicochemical properties.

· Records and monitoring: Detailed records of radioactive drugs and wastes should be established, including their storage location, quantity, activity, and storage time, and regular monitoring and inspection should be conducted.

· Safety measures: The storage area should be equipped with necessary radiation monitoring instruments, such as X/γ ionization survey meters, surface contamination meters, and online radiation monitoring systems, to ensure radiation safety in the storage environment.

· Emergency preparedness: Radiation accident emergency plans should be formulated, and radiation accident emergency kits should be equipped, including protective clothing, monitoring equipment, and decontamination materials, to respond to potential radiation accidents.

· Personnel training: Personnel involved in the storage of radioactive drugs should receive training on radiation safety and protection, and only qualified personnel can work on the job.

· Compliance with regulations: The storage and management of radioactive drugs should comply with relevant laws, regulations, and standards.

The above information is a comprehensive summary from multiple resource documents to ensure the accuracy and completeness of the response. In actual operations, specific laws, regulations, and professional guidelines should be referred to for the storage of radioactive drugs.

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

MICA/B Antibody DM919 Enters Phase 1 Trial for Advanced Solid Tumors by D2M Biotherapeutics
Latest Hotspot
3 min read
MICA/B Antibody DM919 Enters Phase 1 Trial for Advanced Solid Tumors by D2M Biotherapeutics
23 April 2024
D2M Biotherapeutics has initiated a Phase 1 trial by administering the first dose of DM919, an innovative MICA/B antibody, aimed at treating individuals with advanced solid tumors.
Read →
Global first IL-15 drug approved! ImmunityBio's Anktiva receives FDA approval for the treatment of Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
Drug Highlight
7 min read
Global first IL-15 drug approved! ImmunityBio's Anktiva receives FDA approval for the treatment of Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
23 April 2024
On April 22, 2024, ImmunityBio's Anktiva (N-803) plus BCG got FDA approval for BCG-unresponsive NMIBC with CIS, with/without papillary tumors.
Read →
Pathios Gains $25M for Immunotherapy Trials in Series B Funding
Latest Hotspot
3 min read
Pathios Gains $25M for Immunotherapy Trials in Series B Funding
23 April 2024
Pathios Therapeutics Secures $25M in Initial Series B Funding Round to Propel Unique Immunotherapy Strategy into Clinical Trials.
Read →
What are the methods for radiolabeling antibodies?
"What" Series
2 min read
What are the methods for radiolabeling antibodies?
23 April 2024
Commonly used radioactive isotopes include 125I and 131I, which can undergo iodination reactions with the tyrosine residues in the antibody.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.